Table 5.

diagnostic performance of eight lung cancer-antigens in cohort 2.

Protein Description	AUC (95% CI)	Sensitivity (95% CI)	Specificity (95% CI)
DDX6	0.8062 (0.7367 to 0.8905)	73.68% (62.32% to 83.13%)	75.44 (62.24% to 85.87%)
MCCC1	0.7762 (0.6912 to 0.8593)	70.00% (56.79% to 81.15%)	71.67% (58.56% to 82.55%)
ENO1	0.7747 (0.6883 to 0.8611)	75.00% (62.14% to 85.28%)	70.00% (56.79% to 81.15%)
FBXO38	0.7686 (0.6864 to 0.8508)	61.67% (48.21% to 73.93%)	70.00% (56.79% to 81.15%)
14–3–3ζ	0.7656 (0.6789 to 0.8522)	58.33% (44.88% to 70.93%)	78.62% (67.67% to 89.22%)
CSNK1D	0.7615 (0.6744 to 0.8473)	71.67% (58.56% to 82.55%)	73.33% (60.34% to 83.93%)
ESO-1	0.7358 (0.6457 to 0.8259)	70.00% (56.79% to 81.15%)	65.00% (51.60% to 76.87%)
MUC1	0.6636 (0.5634 to 0.7639)	60.34% (46.64% to 72.95%)	60.34% (46.64% to 72.95%)
Combined use of three TAAbs	0.8667 (0.7935 to 0.9499)	81.36% (69.09% to 90.31)%	83.33% (71.48% to 91.71%)

Abbreviations: AUC, the area under receiver operating characteristic curve; CI, confidence interval.